
INOVIO Unveils Promising Data for INO-3107 in Treating RRP
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has announced new data for its leading candidate, INO-3107, which could transform the treatment of recurrent respiratory papillomatosis (RRP). These findings, shared at the …
INOVIO Unveils Promising Data for INO-3107 in Treating RRP Read More